{"id":"W2000963673","doi":"10.1016/j.jval.2011.08.401","title":"PMS15 Costs of Tumor Necrosis Factor Blockers per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured Population","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Intelligent Mechatronic Systems (Canada)","funders":"","keywords":"Medicine; Adalimumab; Etanercept; Infliximab; Psoriatic arthritis; Rheumatoid arthritis; Ankylosing spondylitis; Internal medicine; Discontinuation; Psoriasis; Population; Surgery; Tumor necrosis factor alpha; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00104907,0.0002485145,0.0004420714,0.001361062,0.0001369298,0.0007028667,0.0004832201,0.0004724773,0.001988559],"category_scores_gemma":[0.006091329,0.0002757895,0.001402051,0.00175402,0.0002547117,0.0006347331,0.0004735764,0.0005398404,0.0002500942],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00107307,"about_ca_system_score_gemma":0.0005148682,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01776662,"about_ca_topic_score_gemma":0.01126176,"domain_scores_codex":[0.9989215,0.0003568695,0.0002349693,0.0002124654,0.000176051,0.00009818975],"domain_scores_gemma":[0.9963992,0.001218125,0.001816139,0.0001516591,0.0002443645,0.0001705349],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001133374,0.00007157832,0.9869617,0.00006144604,0.000654539,0.000137902,0.00005472729,0.003988184,0.0001832179,0.0002809062,0.001324863,0.005147602],"study_design_scores_gemma":[0.00007506144,0.0002482669,0.9909341,0.00002929081,0.0002580115,0.0005511852,0.0001254901,0.006540199,0.0002510121,0.0001219403,0.0008536769,0.00001182229],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900674,0.0005811001,0.0003568917,0.0001121353,0.00001014612,0.00001472936,0.008168592,0.00001724408,0.0006718573],"genre_scores_gemma":[0.9944964,0.0001578386,0.000222663,0.00005144182,0.000009606533,0.00001187768,0.004848798,0.000003730412,0.0001975812],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01776662,"threshold_uncertainty_score":0.03532642,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1465185947289173,"score_gpt":0.3822495205097888,"score_spread":0.2357309257808715,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}